Mark Lemko

Simpson College alumnus Mark Lemko graduated with a Bachelor of Arts in Biology. Upon completing his studies, Mark Lemko commenced a career in health care that today spans three decades and numerous high level positions with internationally successful pharmaceutical companies.

At present, Mark Lemko serves as President of dermatological production company Neocutis Inc., in which position he oversees sales, marketing, regulatory finances, and corporate development. Mark Lemko has led Neocutis to become one of the eminent cosmeceutical firms in the industry, focusing on the niche market of wound healing. Neocutis offers high-quality brands that treat dermatological conditions without scarring the skin.

Mark Lemko's decades-long track record includes time as Vice President of Sales and Marketing with Ferndale Laboratories, a specialty dermatological products group serving a global market. Mark Lemko became an integral part of Ferndale Laboratories' growth, helping to define its business model and strategic direction. In addition to his time with Neocutis and Ferndale Laboratories, Mark Lemko launched Da Vinci Life Sciences, a business consulting firm providing commercialization and product development services for other companies in aesthetic pharmaceuticals.

Mark Lemko's Neocutis is based in San Francisco, California.